Runx transcription factors and the developmental balance between cell proliferation and differentiation

Cell Biology International

Volumn 27, Issue 4, 2003, Pages 315-324

  Coffman, James A ^a  

^a STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

AML1; CBFa1; PEBP2; Runt

Indexed keywords

DNA; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROTEIN; PROTEIN P53; STAT PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR RUNX; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BONE DEVELOPMENT; CAENORHABDITIS ELEGANS; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; CLEIDOCRANIAL DYSPLASIA; DEVELOPMENTAL BIOLOGY; DNA BINDING; DNA BINDING MOTIF; DROSOPHILA; EMBRYO DEVELOPMENT; GENE ACTIVATION; GENE CONTROL; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE FUSION; GENE IDENTIFICATION; GENE MUTATION; GENE SILENCING; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; GENOME; HEMATOPOIESIS; HUMAN; LEUKEMIA; LEUKEMOGENESIS; MITOSIS; MOLECULAR INTERACTION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OPEN READING FRAME; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTO ONCOGENE; REGULATOR GENE; REGULATORY MECHANISM; REVIEW; RNA TRANSLATION; SEA URCHIN; SPINAL GANGLION; STOMACH CARCINOMA; STOMACH EPITHELIUM;

ANIMALIA; CAENORHABDITIS; CAENORHABDITIS ELEGANS; ECHINOIDEA; INVERTEBRATA; MAMMALIA; METAZOA; STRONGYLOCENTROTUS; STRONGYLOCENTROTUS PURPURATUS;

EID: 0038440763     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1065-6995(03)00018-0     Document Type: Review

References (83)

1. Adya N., Castilla L.H., Liu P.P. Function of CBFbeta/Bro proteins. Semin Cell Dev Biol. 11:2000;361-368.
2. Akamatsu Y., Ohno T., Hirota K., Kagoshima H., Yodoi J., Shigesada K. Redox regulation of the DNA binding activity in transcription factor PEBP2. The roles of two conserved cysteine residues. J Biol Chem. 272:1997;14497-14500.
3. Amann J.M., Nip J., Strom D.K., Lutterbach B., Harada H., Lenny N., et al. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol Cell Biol. 21:2001;6470-6483.
4. Angerer L.M., Oleksyn D.W., Logan C.Y., McClay D.R., Dale L., Angerer R.C. A BMP pathway regulates cell fate allocation along the sea urchin animal-vegetal embryonic axis. Development. 127:2000;1105-1114.
5. Aronson B.D., Fisher A.L., Blechman K., Caudy M., Gergen J.P. Groucho-dependent and -independent repression activities of Runt domain proteins. Mol Cell Biol. 17:1997;5581-5587.
6. Bangsow C., Rubins N., Glusman G., Bernstein Y., Negreanu V., Goldenberg D., et al. The RUNX3 gene-sequence, structure and regulated expression. Gene. 279:2001;221-232.
7. Ben Aziz-Aloya R., Levanon D., Karn H., Kidron D., Goldenberg D., Lotem J., et al. Expression of AML1-d, a short human AML1 isoform, in embryonic stem cells suppresses in vivo tumor growth and differentiation. Cell Death Differ. 5:1998;765-773.
8. Berardi M.J., Sun C., Zehr M., Abildgaard F., Peng J., Speck N.A., et al. The Ig fold of the core binding factor alpha Runt domain is a member of a family of structurally and functionally related Ig-fold DNA-binding domains. Structure. 7:1999;1247-1256.
9. Buss L.W. The evolution of individuality. 1987;Princeton University Press, Princeton (NJ).
10. Canon J., Banerjee U. Runt and Lozenge function in Drosophila development. Semin Cell Dev Biol. 11:2000;327-336.
11. Charng M.J., Frenkel P.A., Lin Q., Yamada M., Schwartz R.J., Olson E.N., et al. A constitutive mutation of ALK5 disrupts cardiac looping and morphogenesis in mice. Dev Biol. 199:1998;72-79.
12. Coffman J.A., Kirchhamer C.V., Harrington M.G., Davidson E.H. SpRunt-1, a new member of the runt domain family of transcription factors, is a positive regulator of the aboral ectoderm-specific CyIIIA gene in sea urchin embryos. Dev Biol. 174:1996;43-54.
13. Coffman J.A., Kirchhamer C.V., Harrington M.G., Davidson E.H. SpMyb functions as an intramodular repressor to regulate spatial expression of CyIIIa in sea urchin embryos. Development. 124:1997;4717-4727.
14. Coffman J.A., Moore J.G., Calzone F.J., Britten R.J., Hood L.E., Davidson E.H. Automated sequential affinity chromatography of sea urchin embryo DNA binding proteins. Mol Mar Biol Biotechnol. 1:1992;136-146.
15. Corsetti M.T., Calabi F. Lineage- and stage-specific expression of runt box polypeptides in primitive and definitive hematopoiesis. Blood. 89:1997;2359-2368.
16. Crute B.E., Lewis A.F., Wu Z., Bushweller J.H., Speck N.A. Biochemical and biophysical properties of the core-binding factor alpha2 (AML1) DNA-binding domain. J Biol Chem. 271:1996;26251-26260.
17. Daga A., Karlovich C.A., Dumstrei K., Banerjee U. Patterning of cells in the Drosophila eye by Lozenge, which shares homologous domains with AML1. Genes Dev. 10:1996;1194-1205.
18. Davidson E.H., Cameron R.A., Ransick A. Specification of cell fate in the sea urchin embryo: summary and some proposed mechanisms. Development. 125:1998;3269-3290.
19. Duffy J.B., Gergen J.P. The Drosophila segmentation gene runt acts as a position-specific numerator element necessary for the uniform expression of the sex-determining gene Sex-lethal. Genes Dev. 5:1991;2176-2187.
20. Duffy J.B., Kania M.A., Gergen J.P. Expression and function of the Drosophila gene runt in early stages of neural development. Development. 113:1991;1223-1230.
21. Ferguson E.L., Anderson K.V. Decapentaplegic acts as a morphogen to organize dorsal-ventral pattern in the Drosophila embryo. Cell. 71:1992;451-461.
22. Flores G.V., Daga A., Kalhor H.R., Banerjee U. Lozenge is expressed in pluripotent precursor cells and patterns multiple cell types in the Drosophila eye through the control of cell-specific transcription factors. Development. 125:1998;3681-3687.
23. Fujioka M., Yusibova G.L., Sackerson C.M., Tillib S., Mazo A., Satake M., et al. Runt domain partner proteins enhance DNA binding and transcriptional repression in cultured Drosophila cells. Genes Cells. 1:1996;741-754.
24. Gergen J.P., Butler B.A. Isolation of the Drosophila segmentation gene runt and analysis of its expression during embryogenesis. Genes Dev. 2:1988;1179-1193.
25. Golling G., Li L., Pepling M., Stebbins M., Gergen J.P. Drosophila homologs of the proto-oncogene product PEBP2/CBF beta regulate the DNA-binding properties of Runt. Mol Cell Biol. 16:1996;932-942.
26. Gu T.L., Goetz T.L., Graves B.J., Speck N.A. Auto-inhibition and partner proteins, core-binding factor beta (CBFbeta) and Ets-1, modulate DNA binding by CBFalpha2 (AML1). Mol Cell Biol. 20:2000;91-103.
27. Hanai J., Chen L.F., Kanno T., Ohtani-Fujita N., Kim W.Y., Guo W.H., et al. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter. J Biol Chem. 274:1999;31577-31582.
28. Hromas R., Busse T., Carroll A., Mack D., Shopnick R., Zhang D.E., et al. Fusion AML1 transcript in a radiation-associated leukemia results in a truncated inhibitory AML1 protein. Blood. 97:2001;2168-2170.
29. Huang G., Shigesada K., Ito K., Wee H.J., Yokomizo T., Ito Y. Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation. EMBO J. 20:2001;723-733.
30. Inoue K., Ozaki S., Shiga T., Ito K., Masuda T., Okado N., et al. Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat Neurosci. 5:2002;946-954.
31. Kagoshima H., Shigesada K., Satake M., Ito Y., Miyoshi H., Ohki M., et al. The Runt domain identifies a new family of heteromeric transcriptional regulators. Trends Genet. 9:1993;338-341.
32. Kalev-Zylinska M.L., Horsfield J.A., Flores M.V., Postlethwait J.H., Vitas M.R., Baas A.M., et al. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis. Development. 129:2002;2015-2030.
33. Kamachi Y., Ogawa E., Asano M., Ishida S., Murakami Y., Satake M., et al. Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. J Virol. 64:1990;4808-4819.
34. Kania M.A., Bonner A.S., Duffy J.B., Gergen J.P. The Drosophila segmentation gene runt encodes a novel nuclear regulatory protein that is also expressed in the developing nervous system. Genes Dev. 4:1990;1701-1713.
35. Kanno T., Kanno Y., Chen L.F., Ogawa E., Kim W.Y., Ito Y. Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor alpha subunit revealed in the presence of the beta subunit. Mol Cell Biol. 18:1998;2444-2454.
36. Kataoka H., Ochi M., Enomoto K., Yamaguchi A. Cloning and embryonic expression patterns of the zebrafish Runt domain genes, runxa and runxb. Mech Dev. 98:2000;139-143.
37. Kim W.Y., Sieweke M., Ogawa E., Wee H.J., Englmeier U., Graf T., et al. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains. EMBO J. 18:1999;1609-1620.
38. Kitabayashi I., Aikawa Y., Nguyen L.A., Yokoyama A., Ohki M. Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein. EMBO J. 20:2001;7184-7196.
39. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 89:1997;755-764.
40. Lengner C.L., Drissi H., Choi J.-Y., Van Wijnen A.J., Stein J.L., Stein G.S., et al. Activation of the bone-related runx2/cbfa1 promoter in mesenchymal condensations and developing chondrocytes of the axial skeleton. Mech Dev. 114:2002;167-170.
41. Levanon D., Bernstein Y., Negreanu V., Ghozi M.C., Bar-Am I., Aloya R., et al. A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1. DNA Cell Biol. 15:1996;175-185.
42. Levanon D., Bettoun D., Harris-Cerruti C., Woolf E., Negreanu V., Eilam R., et al. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J. 21:2002;3454-3463.
43. Levanon D., Brenner O., Negreanu V., Bettoun D., Woolf E., Eilam R., et al. Spatial and temporal expression pattern of Runx3 (Aml2) and Runx1 (Aml1) indicates non-redundant functions during mouse embryogenesis. Mech Dev. 109:2001a;413-417.
44. Levanon D., Glusman G., Bangsow T., Ben-Asher E., Male D.A., Avidan N., et al. Architecture and anatomy of the genomic locus encoding the human leukemia-associated transcription factor RUNX1/AML1. Gene. 262:2001b;23-33.
45. Levanon D., Goldstein R.E., Bernstein Y., Tang H., Goldenberg D., Stifani S., et al. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proc Natl Acad Sci U S A. 95:1998;11590-11595.
46. Li Q.L., Ito K., Sakakura C., Fukamachi H., Inoue K., Chi X.Z., et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell. 109:2002;113-124.
47. Lindenmuth D.M., Van Wijnen A.J., Hiebert S., Stein J.L., Lian J.B., Stein G.S. Subcellular partitioning of transcription factors during osteoblast differentiation: developmental association of the AML/CBF alpha/PEBP2 alpha-related transcription factor-NMP-2 with the nuclear matrix. J Cell Biochem. 66:1997;123-132.
48. Linggi B., Muller-Tidow C., Van de Locht L., Hu M., Nip J., Serve H., et al. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Nat Med. 8:2002;743-750.
49. Lou J., Cao W., Bernardin F., Ayyanathan K., Rauscher I.F., Friedman A.D. Exogenous cdk4 overcomes reduced cdk4 RNA and inhibition of G1 progression in hematopoietic cells expressing a dominant-negative CBF - a model for overcoming inhibition of proliferation by CBF oncoproteins. Oncogene. 19:2000;2695-2703.
50. Lu J., Maruyama M., Satake M., Bae S.C., Ogawa E., Kagoshima H., et al. Subcellular localization of the alpha and beta subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF. Mol Cell Biol. 15:1995;1651-1661.
51. Lund A.H., Van Lohuizen M. RUNX: a trilogy of cancer genes. Cancer Cell. 1:2002;213-215.
52. Lutterbach B., Westendorf J.J., Linggi B., Isaac S., Seto E., Hiebert S.W. A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia. J Biol Chem. 275:2000;651-656.
53. McCarthy T.L., Ji C., Chen Y., Kim K.K., Imagawa M., Ito Y., et al. Runt domain factor (Runx)-dependent effects on CCAAT/enhancer-binding protein delta expression and activity in osteoblasts. J Biol Chem. 275:2000;21746-21753.
54. Merriman H.L., Van Wijnen A.J., Hiebert S., Bidwell J.P., Fey E., Lian J., et al. The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter. Biochemistry. 34:1995;13125-13132.
55. Miyoshi H., Shimizu K., Kozu T., Maseki N., Kaneko Y., Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci U S A. 88:1991;10431-10434.
56. Nam S., Jin Y.H., Li Q.L., Lee K.Y., Jeong G.B., Ito Y., et al. Expression pattern, regulation, and biological role of runt domain transcription factor, run, in Caenorhabditis elegans. Mol Cell Biol. 22:2002;547-554.
57. Ogawa E., Inuzuka M., Maruyama M., Satake M., Naito-Fujimoto M., Ito Y., et al. Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha. Virology. 194:1993;314-331.
58. Okuda T., Van Deursen J., Hiebert S.W., Grosveld G., Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 84:1996;321-330.
59. Otto F., Kanegane H., Mundlos S. Mutations in the RUNX2 gene in patients with cleidocranial dysplasia. Hum Mutat. 19:2002;209-216.
60. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 89:1997;765-771.
61. Park M.H., Shin H.I., Choi J.Y., Nam S.H., Kim Y.J., Kim H.J., et al. Differential expression patterns of Runx2 isoforms in cranial suture morphogenesis. J Bone Miner Res. 16:2001;885-892.
62. Pelletier N., Champagne N., Stifani S., Yang X.J. MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2. Oncogene. 21:2002;2729-2740.
63. Pozner A., Goldenberg D., Negreanu V., Le S.Y., Elroy-Stein O., Levanon D., et al. Transcription-coupled translation control of AML1/RUNX1 is mediated by cap- and internal ribosome entry site-dependent mechanisms. Mol Cell Biol. 20:2000;2297-2307.
64. Pyronnet S., Pradayrol L., Sonenberg N. A cell cycle-dependent internal ribosome entry site. Mol Cell Biol. 5:2000;607-616.
65. Redondo J.M., Pfohl J.L., Hernandez-Munain C., Wang S., Speck N.A., Krangel M.S. Indistinguishable nuclear factor binding to functional core sites of the T-cell receptor delta and murine leukemia virus enhancers. Mol Cell Biol. 12:1992;4817-4823.
66. Rhoades K.L., Hetherington C.J., Harakawa N., Yergeau D.A., Zhou L., Liu L.Q., et al. Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model. Blood. 96:2000;2108-2115.
67. Robertson A.J., Dickey C.E., McCarthy J.M., Coffman J.A. The expression of SpRunt during sea urchin embryogenesis. Mech Dev. 117:2002;327-330.
68. Rossi F., Maclean H.E., Yuan W., Francis R.O., Semenova E., Lin C.S., et al. p107 and p130 Coordinately regulate proliferation, Cbfa1 expression, and hypertrophic differentiation during endochondral bone development. Dev Biol. 247:2002;271-285.
69. Strom D.K., Nip J., Westendorf J.J., Linggi B., Lutterbach B., Downing J.R., et al. Expression of the AML-1 oncogene shortens the G(1) phase of the cell cycle. J Biol Chem. 275:2000;3438-3445.
70. Tanaka T., Kurokawa M., Ueki K., Tanaka K., Imai Y., Mitani K., et al. The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability. Mol Cell Biol. 16:1996;3967-3979.
71. Tanaka T., Tanaka K., Ogawa S., Kurokawa M., Mitani K., Nishida J., et al. An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms. EMBO J. 14:1995;341-350.
72. Tanaka Y., Watanabe T., Chiba N., Niki M., Kuroiwa Y., Nishihira T., et al. The protooncogene product, PEBP2beta/CBFbeta, is mainly located in the cytoplasm and has an affinity with cytoskeletal structures. Oncogene. 15:1997;677-683.
73. Telfer J.C., Rothenberg E.V. Expression and function of a stem cell promoter for the murine CBFalpha2 gene: distinct roles and regulation in natural killer and T cell development. Dev Biol. 229:2001;363-382.
74. Tracey W.D., Pepling M.E., Horb M.E., Thomsen G.H., Gergen J.P. A Xenopus homologue of aml-1 reveals unexpected patterning mechanisms leading to the formation of embryonic blood. Development. 125:1998;1371-1380.
75. Van der Reijden B.A., Van Ommen G.J., Hagemeijer A., Breuning M.H. Acute myelogenous leukemia: a disorder of gene splicing? Leukemia. 10:1996;204-206.
76. Wang S.W., Speck N.A. Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. Mol Cell Biol. 12:1992;89-102.
77. Westendorf JJ, Hiebert SW. Mammalian runt-domain proteins and their roles in hematopoiesis, osteogenesis, and leukemia. J Cell Biochem Suppl 1999;51-58.
78. Wheeler J.C., Shigesada K., Gergen J.P., Ito Y. Mechanisms of transcriptional regulation by Runt domain proteins. Semin Cell Dev Biol. 11:2000;369-375.
79. Xie T., Spradling A.C. Decapentaplegic is essential for the maintenance and division of germline stem cells in the Drosophila ovary. Cell. 94:1998;251-260.
80. Zaidi S.K., Sullivan A.J., Van Wijnen A.J., Stein J.L., Stein G.S., Lian J.B. Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. Proc Natl Acad Sci U S A. 99:2002;8048-8053.
81. Zeng C., McNeil S., Pockwinse S., Nickerson J., Shopland L., Lawrence J.B., et al. Intranuclear targeting of AML/CBFalpha regulatory factors to nuclear matrix-associated transcriptional domains. Proc Natl Acad Sci U S A. 95:1998;1585-1589.
82. Zeng C., Van Wijnen A.J., Stein J.L., Meyers S., Sun W., Shopland L., Lawrence J.B., Penman S., et al. Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. Proc Natl Acad Sci U S A. 94:1997;6746-6751.
83. Zhang Y.W., Bae S.C., Huang G., Fu Y.X., Lu J., Ahn M.Y., et al. A novel transcript encoding an N-terminally truncated AML1/PEBP2alphaB protein interferes with transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cells. Mol Cell Biol. 17:1997;4133-4145.